Earnings call transcript: Algonquin Power Q4 2025 shows strong growth

Algonquin (AQN) reported Q4 EPS of $0.06, beating the $0.0513 consensus (+16.96%), and Q4 revenue of $630.7M vs $616.56M (+2.29%). Full-year adjusted net earnings rose ~17% to $258.8M and GAAP net earnings increased to $208M; the company used ~$1.6B of sale proceeds to reduce total debt to ~ $6.5B. Management reaffirmed 2026 adjusted EPS guidance (~$0.35–$0.37) and updated 2027 guidance to ~$0.38–$0.42 reflecting a higher expected effective tax rate; valuation metrics cited: P/E ~22.64 and PEG ~0.2. Despite the beat and balance-sheet improvement, AQN stock fell ~11.0% pre-market to $8.40, indicating near-term investor caution likely tied to lost Atlantica dividend income, a CalPeco write-off, and tax/regulatory uncertainty.

Analysis

Market knee‑jerk selling following the print appears driven more by narrative shifts (lost non‑core cash flows, near‑term tax guidance uncertainty, and refinancing optics) than by the regulated utility cash generative base; that creates an asymmetric payoff for patient capital as regulatory outcomes and capex execution are binary catalysts that can re‑rate the multiple. The company’s pivot to a purer regulated profile materially changes the investor base — expect a shift from yield/renewables holders toward utility income and credit investors; that re‑anchoring reduces earnings volatility but can compress short‑term demand for the stock until visible rate implementations roll through.

Second‑order beneficiaries include firms involved in large regional transmission builds and interconnection work: contractors, specialty engineering firms, and project financiers that participate in SPP transmission and behind‑the‑meter upgrades will see multi‑year revenue streams tied to the same capital plan that underpins rate base growth. Conversely, asset managers whose strategies prioritized renewable merchant cash flows will re‑weight away, amplifying near‑term liquidity pressure on the equity but improving availability of credit investors for upcoming refinancings.

Primary risks are timing and regulatory execution: delayed rate implementations, unfavorable metric validation in key jurisdictions, or an elongated refinancing window remain the fastest paths to multiple compression. Watchboard catalysts over the next 3–12 months are tranche refinancing outcomes, formal commission approvals and rate implementation dates, and any board decision on domicile/tax strategy — each can swing consensus EPS and multiple materially.

Key Decisions for Investors

• Long AQN equity via a 9–12 month directional position (or buy-call spread if available) to capture re‑rating as successive regulatory settlements implement; size to 1–2% of portfolio, hedge tail policy risk with a 6–9 month out-of-the-money put (costly tail insurance). Target asymmetric reward of 30–50% upside vs limit loss to ~15% via hedges.
• Pair trade: Long AQN / Short EXC (equal dollar exposure) for 12–18 months to isolate execution on rate case cadence and capex realization; thesis: AQN re‑rating from improved earned ROE and concentrated rate base growth should outperform larger, slower peers. Trim position incrementally on regulatory approvals or if spread narrows to pre‑dislocation levels.
• Credit arbitrage: Buy intermediate‑term LUCO/APUC bonds or use investment‑grade utility bond ETFs to capture spread compression if refinancing executes smoothly; allocate to 2–4% of credit sleeve. Stop‑loss: widen in secondary market spreads beyond 150bps versus benchmark — opportunity for 200–400bp total return from coupon + tightening if execution is clean.
• Event hedge: Buy short‑dated puts on AQN or purchase protection via single‑name CDS (if available) tied to the June refinancing window and tax/domicile decisions; small allocation (notional 0.5–1% portfolio) to protect against a downside re‑pricing should rate implementations be delayed or tax guidance worsen.